Chronic disease program in Iran: Thalassemia control program

BACKGROUND: β-thalassemias (beta-thalassemia) is the most common genetic disorder; it is an inherited globinopathy which is transmitted to people due to a mutation in genes that create globin chain. In Iran, the disease gene is more common in the northern and southern regions. It is estimated that m...

Full description

Bibliographic Details
Main Authors: Ghobad Moradi, Ebrahim Ghaderi
Format: Article
Language:English
Published: Vesnu Publications 2013-02-01
Series:Chronic Diseases Journal
Subjects:
Online Access:http://cdjournal.muk.ac.ir/index.php/cdj/article/view/60
id doaj-329996d8ea7a4c3c9d814c75dc2e39c4
record_format Article
spelling doaj-329996d8ea7a4c3c9d814c75dc2e39c42020-11-25T01:25:39ZengVesnu Publications Chronic Diseases Journal 2345-22262345-22262013-02-01129810610.22122/cdj.v1i2.60Chronic disease program in Iran: Thalassemia control programGhobad Moradi0Ebrahim Ghaderi1Assistant Proffesor, Kurdistan Research Center for Social Determinants of Health (KRCSDH), Kurdistan University of Medical Sciences, Sanandaj, IranAssistant Proffesor, Kurdistan Research Center for Social Determinants of Health (KRCSDH), Kurdistan University of Medical Sciences, Sanandaj, IranBACKGROUND: β-thalassemias (beta-thalassemia) is the most common genetic disorder; it is an inherited globinopathy which is transmitted to people due to a mutation in genes that create globin chain. In Iran, the disease gene is more common in the northern and southern regions. It is estimated that more than 60 mutations of the disease exist in different geographical areas of Iran. Iran has begun to adopt strategies to control the β-thalassemia for two decades; the most important of which is the screening of couples when they want to get marry. The present study aimed to review the thalassemia control program in Iran, the history of the disease, and the disease control strategies. METHODS: This review was conducted according to hand and electronic resources. Books, guidelines and document that exist in thalassemia control program were reviewed in the Iranian Ministry of Health, World Health Organization resources, PubMed, Google Scholar, SID (scientific information database), Magiran and, Iranmedex. RESULTS: Thalassemia program was appropriately structured and has been achieved successes. Reduction the numbers of new cases of β-thalassemia were notably. In some areas, thalassemia program has some defects and the program faced some cultural barriers. CONCLUSION: Due to the improvements in the social and economic situation of the people, it seems necessary to focus on prenatal diagnosis (PND) and pre-implantation genetic diagnosis (PNG) technique strategies and provide their necessary facilities.http://cdjournal.muk.ac.ir/index.php/cdj/article/view/60ThalassemiaSurveillanceEpidemiologyProgramIran
collection DOAJ
language English
format Article
sources DOAJ
author Ghobad Moradi
Ebrahim Ghaderi
spellingShingle Ghobad Moradi
Ebrahim Ghaderi
Chronic disease program in Iran: Thalassemia control program
Chronic Diseases Journal
Thalassemia
Surveillance
Epidemiology
Program
Iran
author_facet Ghobad Moradi
Ebrahim Ghaderi
author_sort Ghobad Moradi
title Chronic disease program in Iran: Thalassemia control program
title_short Chronic disease program in Iran: Thalassemia control program
title_full Chronic disease program in Iran: Thalassemia control program
title_fullStr Chronic disease program in Iran: Thalassemia control program
title_full_unstemmed Chronic disease program in Iran: Thalassemia control program
title_sort chronic disease program in iran: thalassemia control program
publisher Vesnu Publications
series Chronic Diseases Journal
issn 2345-2226
2345-2226
publishDate 2013-02-01
description BACKGROUND: β-thalassemias (beta-thalassemia) is the most common genetic disorder; it is an inherited globinopathy which is transmitted to people due to a mutation in genes that create globin chain. In Iran, the disease gene is more common in the northern and southern regions. It is estimated that more than 60 mutations of the disease exist in different geographical areas of Iran. Iran has begun to adopt strategies to control the β-thalassemia for two decades; the most important of which is the screening of couples when they want to get marry. The present study aimed to review the thalassemia control program in Iran, the history of the disease, and the disease control strategies. METHODS: This review was conducted according to hand and electronic resources. Books, guidelines and document that exist in thalassemia control program were reviewed in the Iranian Ministry of Health, World Health Organization resources, PubMed, Google Scholar, SID (scientific information database), Magiran and, Iranmedex. RESULTS: Thalassemia program was appropriately structured and has been achieved successes. Reduction the numbers of new cases of β-thalassemia were notably. In some areas, thalassemia program has some defects and the program faced some cultural barriers. CONCLUSION: Due to the improvements in the social and economic situation of the people, it seems necessary to focus on prenatal diagnosis (PND) and pre-implantation genetic diagnosis (PNG) technique strategies and provide their necessary facilities.
topic Thalassemia
Surveillance
Epidemiology
Program
Iran
url http://cdjournal.muk.ac.ir/index.php/cdj/article/view/60
work_keys_str_mv AT ghobadmoradi chronicdiseaseprograminiranthalassemiacontrolprogram
AT ebrahimghaderi chronicdiseaseprograminiranthalassemiacontrolprogram
_version_ 1725112775839055872